PEDMARK is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fennec Pharmaceuticals Inc.. The primary component is Sodium Thiosulfate.
Product ID | 73077-010_b7f09611-0c5e-43bb-8dee-900634076dc9 |
NDC | 73077-010 |
Product Type | Human Prescription Drug |
Proprietary Name | PEDMARK |
Generic Name | Sodium Thiosulfate |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-10-03 |
Marketing Category | NDA / |
Application Number | NDA212937 |
Labeler Name | Fennec Pharmaceuticals Inc. |
Substance Name | SODIUM THIOSULFATE |
Active Ingredient Strength | 13 g/100mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-10-03 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
73077-010 | PEDMARK | SODIUM THIOSULFATE |
60267-705 | Sodium Thiosulfate | Sodium Thiosulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PEDMARK 90071857 not registered Live/Pending |
Fennec Pharmaceuticals, Inc. 2020-07-24 |
PEDMARK 87305680 not registered Live/Pending |
Fennec Pharmaceuticals, Inc. 2017-01-18 |